"George Dangas, MD, PhD: Inflammatory Risk in PCI Patients" - Kevin Kunzmann
In a recent study, researchers at the Icahn School of Medicine at Mount Sinai showed that residual inflammatory risk in low LDL-cholesterol patients undergoing percutaneous coronary intervention could be an indicator for risk to major adverse cardiac and cerebrovascular accidents including death, myocardial infarction, or stroke. In discussing the findings, study author George Dangas, MD, PhD, director of cardiovascular innovation at the Zena and Michael A. Weiner Cardiovascular Institute at The Mount Sinai Hospital explains what makes inflammation a relatively early-evidenced but interesting risk factor for cardiovascular events. “The interesting part about this study is that we managed to access patient data that includes measurement of inflammation markers—CRP, specifically—over a period of time. More studies thus far have assessed the importance of CRP in a single measurement.”
— George D. Dangas, MD, PhD, Professor, Medicine, Cardiology, Surgery, Icahn School of Medicine at Mount Sinai, Director, Cardiovascular Innovation, The Zena and Michael A. Weiner Cardiovascular Institute, The Mount Sinai Hospital